Mesoporous Silica Nanoparticle as a Potential Nanocarrier to Improve the Effectiveness of Antiobesity Drugs. [PDF]
Aulifa DL +5 more
europepmc +1 more source
Anti-dengue activity of a cellular lipid uptake inhibitor, lipofermata. [PDF]
Thongon S +7 more
europepmc +1 more source
Precision obesity medicine: A phenotype-guided framework for pharmacologic therapy across the lifespan. [PDF]
Tuccinardi D +9 more
europepmc +1 more source
ORLISTAT : Kan orlistat ha andra hälsoeffekter i kroppen förutom viktminskningseffekten?
Faisal Mohammadshahi
openalex +1 more source
Orlistat Confers Neuroprotection in Traumatic Brain Injury by Modulating Microglial Lipid Metabolism. [PDF]
Yu C +11 more
europepmc +1 more source
In vitro and in silico antiglycation antihyperglycemic and anti-inflammatory properties of chemically profiled fruit extracts of Solanum obtusifolium Dunal. [PDF]
Abdnim R +11 more
europepmc +1 more source
Economic Evaluation of Medications in Prevention and Treatment of Obesity: A Systematic Review. [PDF]
Afshari S +7 more
europepmc +1 more source
Anti-Obesity Drug Orlistat (Xenical) Is a Novel Antitumor Medication
Leila Azadbakht +2 more
openalex +1 more source
Synthetic pancreatic lipase inhibitors in obesity treatment: current updates on <i>in silico</i> design, synthesis, bioactivity, and SAR. [PDF]
Jagtap UA, Paul AT.
europepmc +1 more source
Medical Management of Obesity: A Comprehensive Review of Food and Drug Administration (FDA)-Approved and Investigational Therapies. [PDF]
Raza SS +4 more
europepmc +1 more source

